Publications by authors named "John Wunderlich"

Claim this Profile
U
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.
Maria R Parkhurst, Paul F Robbins, Eric Tran, Todd D Prickett, Jared J Gartner, John R Wunderlich

Cancer Discov· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers.
Sanja Stevanović, Sarah R Helman, John R Wunderlich, Michelle M Langhan, Stacey L Doran

Clin Cancer Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell Responses to "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers.
Drew C Deniger, Anna Pasetto, Paul F Robbins, Jared J Gartner, Todd D Prickett, John R Wunderlich

Clin Cancer Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer.
Yasmine Assadipour, Nikolaos Zacharakis, Jessica S Crystal, Todd D Prickett, Jared J Gartner, John R Wunderlich

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.
Smita S Chandran, Robert P T Somerville, James C Yang, Richard M Sherry, Christopher A Klebanoff, John R Wunderlich

Lancet Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma.
Drew C Deniger, Mei Li M Kwong, Anna Pasetto, Mark E Dudley, John R Wunderlich

Clin Cancer Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.
Stephanie L Goff, Mark E Dudley, Deborah E Citrin, Robert P Somerville, John R Wunderlich

J Clin Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.
Luke D Rothermel, Arvind C Sabesan, Daniel J Stephens, Smita S Chandran, Biman C Paria, John R Wunderlich

Clin Cancer Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
Alena Gros, Maria R Parkhurst, Eric Tran, Anna Pasetto, Paul F Robbins, John R Wunderlich

Nat Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of somatic mutations in human gastrointestinal cancers.
Eric Tran, Mojgan Ahmadzadeh, Yong-Chen Lu, Alena Gros, Simon Turcotte, John R Wunderlich

Science· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.
Sanja Stevanović, Lindsey M Draper, Michelle M Langhan, Tracy E Campbell, Mei Li Kwong, John R Wunderlich

J Clin Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.
Paul F Robbins, Sadik H Kassim, Thai L N Tran, Jessica S Crystal, Richard A Morgan, John R Wunderlich

Clin Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans.
Smita S Chandran, Biman C Paria, Abhishek K Srivastava, Luke D Rothermel, Daniel J Stephens, John R Wunderlich

Clin Cancer Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.
Todd D Prickett, Brad J Zerlanko, Victoria K Hill, Jared J Gartner, Nouar Qutob, John Wunderlich

J Invest Dermatol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology.
Zoltan Pos, Tara L Spivey, Hui Liu, Michele Sommariva, Jinguo Chen, John R Wunderlich

J Invest Dermatol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration.
Edmund K Bartlett, Patricia A Fetsch, Armando C Filie, Andrea Abati, Seth M Steinberg, John R Wunderlich

Clin Cancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.
Alena Gros, Paul F Robbins, Xin Yao, Yong F Li, Simon Turcotte, John R Wunderlich

J Clin Invest· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.
Eric Tran, Simon Turcotte, Alena Gros, Paul F Robbins, Yong-Chen Lu, John R Wunderlich

Science· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy.
Simon Turcotte, Alena Gros, Eric Tran, Chyi-Chia R Lee, John R Wunderlich

Clin Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy.
Simon Turcotte, Alena Gros, Katherine Hogan, Eric Tran, Christian S Hinrichs, John R Wunderlich

J Immunol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy.
Rachel E Beard, Daniel Abate-Daga, Shannon F Rosati, Zhili Zheng, John R Wunderlich

Clin Cancer Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.
Mark E Dudley, Colin A Gross, Robert P T Somerville, Young Hong, Nicholas P Schaub, John R Wunderlich

J Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma.
Alena Gros, Simon Turcotte, John R Wunderlich, Mojgan Ahmadzadeh, Mark E Dudley

Clin Cancer Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes.
Kevin M Friedman, Peter A Prieto, Laura E Devillier, Colin A Gross, James C Yang, John R Wunderlich

J Immunother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma.
Melissa M Alvarez-Downing, Suzanne M Inchauste, Mark E Dudley, Donald E White, John R Wunderlich

World J Surg Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis